Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based...

|By:, SA News Editor

Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based on the American College of Obstetricians and Gynecologists Committee on Genetics recommendation that cell-free fetal DNA testing be used in high-risk women. The firm also doubles its price target to $8 from $4.